Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 29 April 2005:
Vol. 308. no. 5722, pp. 618 - 621
DOI: 10.1126/science.308.5722.618
Prev | Table of Contents | Next

News Focus

PUBLIC HEALTH:
High Hopes and Dilemmas for a Cervical Cancer Vaccine

Jon Cohen

As two vaccines against a sexually transmitted virus approach the market, public health experts are debating who should receive them--women, boys, or girls--and how to make them affordable in developing countries where the need is highest.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Paradox of vaccination in cervical cancer and screening.
C. A Gericke (2008)
BMJ 337, a1049
   Full Text »
Comprehensive comparison of the interaction of the E2 master regulator with its cognate target DNA sites in 73 human papillomavirus types by sequence statistics.
I. E. Sanchez, M. Dellarole, K. Gaston, and G. de Prat Gay (2008)
Nucleic Acids Res. 36, 756-769
   Abstract »    Full Text »    PDF »
Modeling Human Papillomavirus Vaccine Effectiveness: Quantifying the Impact of Parameter Uncertainty.
N. Van de Velde, M. Brisson, and M.-C. Boily (2007)
Am. J. Epidemiol. 165, 762-775
   Abstract »    Full Text »    PDF »
Human Papillomavirus Vaccines.
M. R Schmiedeskamp and D. R Kockler (2006)
Ann. Pharmacother. 40, 1344-1352
   Abstract »    Full Text »    PDF »
The promise of the human papillomavirus vaccine does not confer immunity against ethical reflection..
I. de Melo-Martin (2006)
Oncologist 11, 393-396
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)